These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 21122639

  • 1. Evaluation of a pharmacist-managed lipid clinic that uses point-of-care lipid testing.
    Gerrald KR, Dixon DL, Barnette DJ, Williams VG.
    J Clin Lipidol; 2010; 4(2):120-5. PubMed ID: 21122639
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effectiveness of a pharmacy care management program for veterans with dyslipidemia.
    Smith MC, Boldt AS, Walston CM, Zillich AJ.
    Pharmacotherapy; 2013 Jul; 33(7):736-43. PubMed ID: 23625745
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Attainment of low-density lipoprotein cholesterol goals in coronary artery disease.
    Kauffman AB, Olson KL, Youngblood ML, Zadvorny EB, Delate T, Merenich JA, Clinical Pharmacy Cardiac Risk Service Study Group.
    J Clin Lipidol; 2010 Jul; 4(3):173-80. PubMed ID: 21122649
    [Abstract] [Full Text] [Related]

  • 7. Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting.
    Mosca L, Merz NB, Blumenthal RS, Cziraky MJ, Fabunmi RP, Sarawate C, Watson KE, Willey VJ, Stanek EJ.
    Circulation; 2005 Feb 01; 111(4):488-93. PubMed ID: 15687138
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: the alliance study.
    Koren MJ, Hunninghake DB, ALLIANCE Investigators.
    J Am Coll Cardiol; 2004 Nov 02; 44(9):1772-9. PubMed ID: 15519006
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T, Denke M, McBride P, Battisti WP, Brady WE, Palmisano J.
    Am J Geriatr Pharmacother; 2005 Dec 02; 3(4):218-28. PubMed ID: 16503317
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Achieving cholesterol target in a managed care organization (ACTION) trial.
    Straka RJ, Taheri R, Cooper SL, Smith JC.
    Pharmacotherapy; 2005 Mar 02; 25(3):360-71. PubMed ID: 15843283
    [Abstract] [Full Text] [Related]

  • 20. Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting.
    Bullano MF, Wertz DA, Yang GW, Kamat S, Borok GM, Gandhi S, McDonough KL, Willey VJ.
    Pharmacotherapy; 2006 Apr 02; 26(4):469-78. PubMed ID: 16553504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.